Help us improve our site.
Elisabeth has been a leadership volunteer with the Canadian Cancer Society for nineteen years, starting as the Daffodil Days fundraising chair in Hamilton. In an effort to find volunteers for that first campaign, and to promote the sale, she met with members of the local media and appeared in print, on television and on radio stations. Although working with the media was new to her, those first meetings led to a good working relationship with the media. As a result, in addition to being involved with Daffodil Days, she also became the Media Relations Chair and later the Fundraising Chair. After the local branches closed, Elisabeth became Vice President of the Hamilton Unit and served for three years as President. While representing the Hamilton Unit at Central West Region, she facilitated regional workshops at Mohawk College and served as a member of the Regional Awards committee. She has been the Regional Representative for Central West region for the past year.
Elisabeth remembers Canadian Cancer Society daffodils being in her home each spring from the time she was a young child. As many of her immediate relatives have been diagnosed with different forms of cancer throughout her life, she decided to contribute her time to the Canadian Cancer Society because of its commitment to providing patient support services, public awareness campaigns and research funding for all types of cancer. In addition to her work with the Canadian Cancer Society, Elisabeth served for two years as a lay delegate for the Ontario Institute for Cancer Research. She has also served as a Board member of a brain injury support group and is also actively involved in her local school and church.
Elisabeth lives in Hamilton with her husband Malcolm and their young son. Together they enjoy hosting Canadian Cancer Society meetings and events in their home.
Clinical trial discovery improves quality of life
A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.